Rayner’s Most Technologically Advanced IOL
The Sulcoflex Trifocal combines Rayner’s pseudophakic supplementary Sulcoflex platform — designed to be implanted in the ciliary sulcus and with over 10 years of successful outcomes — with the patented trifocal optic technology of the recently launched RayOne Trifocal IOL.
The reversibility afforded by the Sulcoflex Trifocal means that surgeons can now treat an even wider range of patients for presbyopia, to meet both their visual and lifestyle needs.
High patient satisfaction1,4,6
Reduced surgical risk associated with IOL exchange1,4,6
“The world’s first trifocal supplementary IOL may be used in routine cataract-procedures (DUET) or in pseudophakes for presbyopic correction. This IOL-concept allows the surgeon to adjust the optical system to any unpredictable situation in the future.”
Michael Amon MD, Professor and Head of the Department of Ophthalmology at the Academic Teaching Hospital of St John, Vienna, Austria